DGFT amends measurement for key inputs under standard input output norms for exporting metformin HCL: Shardul Nautiyal, Mumbai Monday, December 15, 2025, 08:00 Hrs [IST] The Direc ...

Overcoming acquired treatment resistance is one of the major challenges in the fight against cancer. While combination ...

Overcoming acquired treatment resistance is one of the major challenges in the fight against cancer. While combination ...

Researchers at the University of Geneva (UNIGE) have developed in vitro models of the kidneys, liver and heart for the ...

Published on A team from UNIGE has developed in vitro organ models to test their sensitivity to novel cancer therapies.

Overcoming acquired treatment resistance is one of the major challenges in the fight against cancer. While combination therapies hold promise, their toxicity to healthy tissue remains a major hurdle.

HCL Technologies Limited is a technology company. It is engaged in providing a range of information technology (IT) and business services, engineering and research and development (R&D) services and ...